Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TRYP Therapeutics Inc C.TRYP

Healthcare
Tryp Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric... see more

Bullboard (CSE:TRYP)

View:
1 2 3 4 5 6 Next
Post by Betteryear2on Jul 13, 2023 6:58am

Tryp Therapeutics Receives Confirmation From FDA To Proceed

KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on ...more  
195
Post by Blackpennyon Sep 06, 2022 10:59pm

Making money else where!

Sold off half to free up cash not doing any thing in all most 2 years.
437
Post by FastFFon Feb 28, 2022 2:38pm

Well, I'm impressed

Somebody has a working brain. Changed the financing - now no warrants + a fat premium to "market" makes TRYP look super attractive. They have several drugs in phase 2. The other ones that ...more  
391
Post by FastFFon Feb 04, 2022 3:33pm

Lovely - free warrant for the VC

And he just fired the management team. Chart looks like a ski slope.....all downhill
228
Post by lithiumson Feb 04, 2022 8:58am

Halt trading

  Tryp Therapeutics halted at open   2022-02-04 08:36 ET - Halt Trading   Tryp Therapeutics Inc. has been halted at the open on Feb. 4, 2022.
223
Post by JayDesturaon Nov 17, 2021 10:13am

🎉📣FSD Pharma's Research and Clinical Advisory Board📢

Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical Advisory Board. FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA ...more  
224
Post by Betteryear2on Oct 07, 2021 7:23am

Collaboration with Researchers

Tryp has partnered with Paul Hutson, PharmD and Christopher Nicholas, PhD to advance the Company's proprietary, psilocybin-based drug product San Diego, California--(Newsfile Corp. - October 7 ...more  
186
Post by Betteryear2on Aug 10, 2021 7:07am

Partners with Calvert Labs

Tryp has also entered into an agreement with Gad Consulting Services to collaborate on the preclinical studies San Diego, California--(Newsfile Corp. - August 10, 2021) - Tryp Therapeutics  ...more  
164
Post by SkywalkerofLukeon Jul 26, 2021 6:22pm

Video on $TRYP

Been bullish on $TRYP for a while now with the cannabis/psychedelics market starting to go mainstream, and now they're currently working towards getting their psilocybin treatment FDA approved ...more  
183
Post by maysilverstoneon Jul 23, 2021 12:20pm

$TRYP- Psychedelic stock to watch

  They are working to get their psilocybin treatments approved by the FDA and on the market. By targeting the 505 b2 and the orphan drug design, $TRYP is granted the " ...more  
134
Post by Snyderman88on Jul 22, 2021 1:10pm

Tryp Therapeutics, my psychedelic sectors buy low option

As I continue my dive in to psychedelic treatments, Tryp Therapeutics has jumped out at me.     Tryp Therapeutics (Ticker: TRYP.c TRYPF) is a San Diego-based pharmaceutical ...more  
149
Post by StockHawk1on Jul 21, 2021 3:13pm

Great news for Tryp

Tryp Therapeutics ( $TRYP ) has begun phase 2 trials of their TRYP-8802 oral formulation with the University of Michigan. TRYP-8802 is synthetic psilocybin  Tryp and UoM are testing the ...more  
184
1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities